The monthslong battle over the future of the weight-loss drug industry is headed for a climax this week, when the Food and ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 496.78% and ...

Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a ...

Investors' focus could, however, shift back onto the possible market impacts of GLP-1 agonists in 2025, particularly as a result of a major expansion of current supplies after Novo Nordisk was given a ...

The president-elect is set to appear with SoftBank Group CEO Masayoshi Son at Mar-a-Lago on Monday. The industrial conglomerate said its board continued to explore strategic alternatives and plans to ...

Morris & Dickson today announces the formation of their 2025 Health System Advisory Board to advise and guide the company in its delivery of pharmaceuticals and services to healthcare providers across ...

Telehealth firm Ro will offer low-cost, single-dose vials of Lilly's obesity drug Zepbound, the first alternative to the new LillyDirect DTC channel. Join the conversation, on Tuesday 28th January ...